Factors Indicating Need for Dose Escalation Increase doses when minimal subjective improvements after 3-4 weeks at current dose, IGF-1 levels show minimal or no meaningful increase from baseline after an adequate trial period (e.g., 812 weeks), good tolerance without significant side effects suggesting room for higher dosing, and treatment goals require more aggressive approach than current dose provides
Effectiveness varies widely by category
The NO Super Pump Volumising Complex in Shock Therapy features a proprietary blend of Arginine AKG, Citrulline Malate, and Carnosine, all designed to boost nitric oxide production
Holm VA : Pipes: food and children with Prader-Willi syndrome
These figures add up to more than 100% since many plaintiffs are alleging multiple side effects from taking GLP-1 drugs
Before anything else touches your plate